Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SIEN

Sientra (SIEN) Stock Price, News & Analysis

Sientra logo

About Sientra Stock (NASDAQ:SIEN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.17
$0.68
52-Week Range
N/A
Volume
3.44 million shs
Average Volume
4.15 million shs
Market Capitalization
$2.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Receive SIEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sientra and its competitors with MarketBeat's FREE daily newsletter.

SIEN Stock News Headlines

Most traders are panicking. We’re cashing in
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…
See More Headlines

SIEN Stock Analysis - Frequently Asked Questions

Sientra, Inc. (NASDAQ:SIEN) posted its quarterly earnings data on Wednesday, November, 10th. The medical instruments supplier reported ($0.80) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.60) by $1.80. The medical instruments supplier earned $19.62 million during the quarter, compared to analyst estimates of $18.10 million.

Sientra shares reverse split on the morning of Monday, January 23rd 2023. The 1-10 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sientra investors own include Meta Platforms (META), NVIDIA (NVDA), Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Alibaba Group (BABA), Pfizer (PFE) and Verizon Communications (VZ).

Company Calendar

Last Earnings
11/10/2021
Today
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:SIEN
Employees
304
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-73,310,000.00
Pretax Margin
-65.68%

Debt

Sales & Book Value

Annual Sales
$90.55 million
Price / Cash Flow
N/A
Book Value
($0.04) per share
Price / Book
N/A

Miscellaneous

Free Float
11,775,000
Market Cap
$2.08 million
Optionable
Optionable
Beta
2.04

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:SIEN) was last updated on 5/13/2025 by MarketBeat.com Staff
From Our Partners